Northern Trust’s Co-Diagnostics CODX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,833
Closed -$9.27K 4433
2025
Q4
$9.27K Hold
1,833
﹤0.01% 4437
2025
Q3
$18.9K Hold
1,833
﹤0.01% 4380
2025
Q2
$15.4K Hold
1,833
﹤0.01% 4356
2025
Q1
$17K Hold
1,833
﹤0.01% 4352
2024
Q4
$41.2K Hold
1,833
﹤0.01% 4286
2024
Q3
$68.7K Hold
1,833
﹤0.01% 4142
2024
Q2
$68.7K Sell
1,833
-1
-0.1% -$36 ﹤0.01% 4140
2024
Q1
$61.6K Sell
1,834
-8
-0.4% -$290 ﹤0.01% 4189
2023
Q4
$73.5K Hold
1,842
﹤0.01% 4166
2023
Q3
$58.6K Sell
1,842
-24
-1% -$907 ﹤0.01% 4132
2023
Q2
$62.1K Sell
1,866
-206
-10% -$7.88K ﹤0.01% 4160
2023
Q1
$92K Buy
2,072
+19
+0.9% +$1.52K ﹤0.01% 4103
2022
Q4
$155K Buy
2,053
+183
+10% +$17.1K ﹤0.01% 3964
2022
Q3
$180K Buy
1,870
+174
+10% +$24.3K ﹤0.01% 3920
2022
Q2
$286K Buy
1,696
+126
+8% +$19.2K ﹤0.01% 3739
2022
Q1
$291K Sell
1,570
-50
-3% -$10.4K ﹤0.01% 3960
2021
Q4
$434K Sell
1,620
-14
-0.9% -$3.67K ﹤0.01% 3865
2021
Q3
$477K Sell
1,634
-25
-2% -$7.3K ﹤0.01% 3780
2021
Q2
$410K Sell
1,659
-7,911
-83% -$2.03M ﹤0.01% 3802
2021
Q1
$2.74M Sell
9,570
-646
-6% -$258K ﹤0.01% 3082
2020
Q4
$2.85M Buy
10,216
+105
+1% +$38.9K ﹤0.01% 3000
2020
Q3
$4.12M Sell
10,111
-140
-1% -$71.9K ﹤0.01% 2653
2020
Q2
$5.95M Buy
10,251
+9,568
+1,401% +$4.37M ﹤0.01% 2408
2020
Q1
$156K Buy
+683
New +$118K ﹤0.01% 3730

Other funds holding CODX

Northern Trust's CODX Position: Q1 2026 in Review

Northern Trust sold out of Co-Diagnostics (CODX) in Q1 2026, closing a stake of 1,833 shares — an estimated $9.27K sold.

Northern Trust first reported a position in CODX in Q1 2020 and held it in 24 quarters. The position peaked at $5.95M in Q2 2020. 14 funds tracked by Wall St. Rank hold CODX as of Q1 2026.

  • Northern Trust reported no remaining Co-Diagnostics position as of Q1 2026 after selling out during the quarter.
  • Northern Trust sold 1,833 Co-Diagnostics shares in Q1 2026, an estimated $9.27K.
  • Northern Trust first reported a position in Co-Diagnostics in Q1 2020 and held it in 24 quarters.
  • Northern Trust's Co-Diagnostics position peaked at $5.95M in Q2 2020.
  • 14 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.